Home » Newsletters » BioWorld Science

BioWorld Science

July 31, 2008

View Archived Issues

FDA advisory committee recommends approval of Chugai and Roche's Actemra in RA

Integrated BioPharma sets record and distribution dates for spin-off of iBioPharma

[11C]-AFM, a novel PET imaging agent to visualize serotonin transporters

FDA accepts for filing Meda's registration application for Sublinox

Zogenix secures financing to launch sumatriptan DosePro

Chroma Therapeutics' CHR-3996 histone deacetylase inhibitor to be evaluated in a phase I study

Phase II results of AL-108 for amnestic MCI presented at ICAD meeting

Novel GSK-3 inhibitor increases neuron survival and attenuates neuropathology in transgenic AD mice

Millennium presents an update on clinical development

Pronucleon peptide technology effective for beta amyloid imaging in mice

Lexicon reports results from phase I study of LX-1031 in IBS

Inspire modifies clinical protocol for phase III TIGER-2 trial of denufosol tetrasodium in CF

Intercept completes USD 25 million equity financing

GSK launches Volibris for pulmonary arterial hypertension in the U.K.

Ariad initiates phase II clinical trial of deforolimus in breast cancer

Hollis-Eden initiates phase I/II clinical trial of Apoptone in late-stage prostate cancer

FDA approves Noven's Stavzor for bipolar disorder, seizures and migraine headaches

Novel antiinfective agents reported in recent patents

Idenix presents an update on the company's clinical development plans

Bristol-Myers Squibb prepares and tests novel factor VIIa inhibitors

New agents for diagnosis of congestive heart failure described in BMS patent

ReceptoPharm successfully completes phase IIb/IIIa clinical trial of RPI-78M in AMN

Regulatory approval of Basilea's Toctino recommended under European decentralized procedure

Infinity initiates phase I clinical trial of IPI-493 in advanced solid tumors

Othera submits IND application to FDA for OT-730 in glaucoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...